Analysis | Paracetamol | Control | DIM or OR (95% CI | Metoclopramide | Control | DIM or OR (95% CI | Ceftriaxone | Control | DIM or OR (95% CI | |
---|---|---|---|---|---|---|---|---|---|---|
mRS, median | aOLR | Median [IQR] | Median [IQR] | aOR (95% CI) | Median [IQR] | Median [IQR] | aOR (95% CI) | Median [IQR] | Median [IQR] | aOR (95% CI) |
Sensitivity analyses | ||||||||||
mRS, unadjusted | OLR | Median [IQR] | Median [IQR] | OR (95% CI) | Median [IQR] | Median [IQR] | OR (95% CI) | Median [IQR] | Median [IQR] | OR (95% CI) |
mRS, imputed | aOLR | Median [IQR] | Median [IQR] | aOR (95% CI) | Median [IQR] | Median [IQR] | aOR (95% CI) | Median [IQR] | Median [IQR] | aOR (95% CI) |
mRS, mean | aMLR | Mean (SD) | Mean (SD) | aDIM (95% CI) | Mean (SD) | Mean (SD) | aDIM (95% CI) | Mean (SD) | Mean (SD) | aDIM (95% CI) |
mRS > 2 | aBLR | n (%) | n (%) | aOR (95% CI) | n (%) | n (%) | aOR (95% CI) | n (%) | n (%) | aOR (95% CI) |
Death | aCPHR | n (%) | n (%) | aHR (95% CI) | n (%) | n (%) | aHR (95% CI) | n (%) | n (%) | aHR (95% CI) |